| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 06/19/2002 | EP1214077A2 Local delivery of 17-beta estradiol for preventing vascular intima hyperplasia and for improving vascular endothelium function after vascular injury |
| 06/19/2002 | CN1354184A Method for synthesizing 2-methoxyestradiol and application of its product |
| 06/13/2002 | WO2001074839A3 Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use |
| 06/12/2002 | EP1212618A1 Effect of steroids on nmda receptors depends on subunit composition |
| 06/12/2002 | EP1212345A2 Orally active 7.alpha.-alkyl androgens |
| 06/06/2002 | WO2001052856A3 Use of dehydroepiandrosterone, its precursors and derivatives, by oral administration, as hydrating agents with direct action |
| 06/06/2002 | DE10048524A1 Kresolabtrennung aus Stutenharn Cresol separation from Stutenharn |
| 06/05/2002 | EP0684825B1 Kit for preventing or inhibiting fertilization |
| 05/30/2002 | WO2002042319A2 2-substituted estrogens as antiangiogenic agents |
| 05/30/2002 | WO2001023405A3 Therapeutic treatment of androgen receptor driven conditions |
| 05/30/2002 | US20020065258 Esteradiol derivatives at the position of 1 and 17 in gonane ring containing a group selected from hydroxy, ester, ether or sulfamate |
| 05/30/2002 | US20020065257 17beta-amino and hydroxylamino-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 05/30/2002 | US20020064790 Generating nucleotide sequence binding ligand; obtain ligandthat binds to nucleotide sequence, monitor binding activity of particle and sequences, recover ligands that utilizes reduced energy to bind sequences compare to wild type |
| 05/30/2002 | CA2430100A1 Antiangiogenic agents |
| 05/29/2002 | EP1208842A2 Regulation of the immune system |
| 05/28/2002 | US6395492 Derivatized oligonucleotides having improved uptake and other properties |
| 05/22/2002 | EP1206480A2 Methods of obtaining 2-methoxyestradiol of high purity |
| 05/16/2002 | WO2002038582A2 Method for the production of 4-(17alpha substituted 3-oxoestra-4,9-dien-11-yl)benzaldehyd-(1e or 1z)-oximes |
| 05/16/2002 | WO2002038581A2 Method for the production of 4-(17alpha-methyl substituted 3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1e or 1z)-oximes |
| 05/16/2002 | US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 05/16/2002 | DE10056676A1 Preparation of estradienyl-benzaldoxime derivative preparation in high yield, for use e.g. in treating endometriosis, from epoxy-estrenone by multi-stage process including selective Grignard reaction |
| 05/16/2002 | DE10056675A1 Preparation of estradienyl-benzaldoxime derivative preparation in high yield, for use e.g. in treating endometriosis, from estradienone by multi-stage process including selective Grignard reaction |
| 05/10/2002 | WO2002036605A2 Estrone-derivatives having cytoprotective activity |
| 05/10/2002 | WO2001026618A3 Composition, especially a cosmetic composition, containing a steroid and a liposoluble uv filter |
| 05/08/2002 | EP1203011A1 Orally active androgens |
| 05/08/2002 | CN1348373A Use of 17-ketosteroids for the treatment of malaria and Trypanosomiasis |
| 05/07/2002 | US6384251 5-ene steroids such as dehydroepiandrosterone; ketone products |
| 05/07/2002 | US6384025 Skin disorders; reacting retinol with chloroformate compound |
| 05/07/2002 | US6383766 Reduced cortisol conjugates |
| 05/02/2002 | WO2001058919A3 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 05/02/2002 | WO2001040253A3 3-methylene steroid derivative for the treatment of autoimmune diseases |
| 05/02/2002 | WO2001035949A3 Treatment or systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 05/02/2002 | US20020052352 Treating a malignant tumor, like a melanoma, using plant-derived compounds |
| 05/02/2002 | EP0615448B1 Sex steroid activity inhibitors |
| 04/25/2002 | WO2002032429A2 Use of inhibitors of progesterone receptor for treating cancer |
| 04/25/2002 | CA2423013A1 Use of inhibitors of progesteron receptor for treating cancer |
| 04/24/2002 | CN1346364A 16-hydroxyestratrienes as selective estrogens |
| 04/24/2002 | CN1346273A Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
| 04/18/2002 | US20020045774 Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain |
| 04/18/2002 | US20020045772 E.g., 2 beta-(2-iodoethyloxy)-1 alpha ,3 beta ,25-tris(triethylsilyloxy)cholesta-5,7-diene |
| 04/18/2002 | US20020045746 Form L crystalline eplerenone having a monoclinic crystal system and an X-ray powder diffraction pattern with a peak at 8. 0+-0.2 degrees 2 theta . |
| 04/18/2002 | DE10049736A1 17alpha-Fluoralkylsteroide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen 17alpha-Fluoroalkyl steroids, processes for their preparation and pharmaceutical compositions containing them |
| 04/17/2002 | EP1196427A2 Novel c-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 04/17/2002 | EP0970103B1 Antigestagenic steroids with a fluorinated 17alpha-alkyl chain |
| 04/11/2002 | WO2002028880A2 Compounds useful for treating hypertriglyceridemia |
| 04/11/2002 | WO2001032680A3 18-nor-steroids as selectively active estrogens |
| 04/11/2002 | CA2424581A1 Compounds useful for treating hypertriglyceridemia |
| 04/10/2002 | EP1087986B1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity |
| 04/10/2002 | CN1344272A Method for producing 4,4-dimethyl-3 beta-hydroxypregna-8, 14-diene-21-carboxylic acid esters and intermediate products obtained by said method |
| 04/09/2002 | US6369047 Androgenic steroid compounds and a method of making and using the same |
| 04/04/2002 | WO2002026760A2 Separation of cresol from mare's urine |
| 04/04/2002 | WO2002026759A2 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 04/04/2002 | WO2001060375A3 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration |
| 04/04/2002 | CA2422056A1 17.alpha. fluoroalkyl steroids, method for producing the same and pharmaceutical compositions containing said compounds |
| 04/03/2002 | CN1342654A C21 steriod glycoside extracted from white fleece flower root with antineoplastic function |
| 03/29/2002 | WO2003045398A1 Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/28/2002 | US20020038021 Eplerenone crystalline form exhibiting enhanced dissolution rate |
| 03/28/2002 | US20020038004 1,2-phenylenediboronic acid reagents and complexes |
| 03/27/2002 | EP1189922A1 Steroid derivatives |
| 03/26/2002 | US6362173 Methods for treating psychosis associated with cocaine addiction with glucocorticoid receptor antagonists |
| 03/21/2002 | WO2002022645A2 Method of making 7alpha-methyl-11beta-methoxy estradiol and related compounds with estrogenic activity |
| 03/21/2002 | WO2001051055A3 Pharmaceutical compositions containing steroidal structures and uses thereof |
| 03/21/2002 | US20020035100 Alkyl ether modified polycyclic compounds having a terminal phenol and uses for protection of cells |
| 03/20/2002 | EP1187846A2 11beta long-chain substituted estratrienes, method for their production, pharmaceutical preparations containing said 11beta long-chain substituted estratrienes, and their use for producing medicaments |
| 03/20/2002 | EP0730458B1 Use of aldosterone antagonists to inhibit myocardial fibrosis |
| 03/14/2002 | WO2002020020A1 Exemestane as chemopreventing agent |
| 03/14/2002 | CA2419590A1 Exemestane as chemopreventing agent |
| 03/07/2002 | WO2002017967A1 Method of increasing testosterone and related steroid concentrations in women |
| 03/07/2002 | WO2002017927A1 Method for treating erectile dysfunction and increasing libido in men |
| 03/07/2002 | CA2746787A1 Method of increasing testosterone and related steroid concentrations in women |
| 03/06/2002 | EP0912186B1 Progestogen-anti-progestogen regimens |
| 03/05/2002 | US6352980 Estrenes for inducting hypothalamic effects |
| 03/05/2002 | CA2056638C 2 .beta., 19-ethylene bridged steroids as aromatase inhibitors |
| 02/28/2002 | WO2002016395A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
| 02/28/2002 | WO2002016391A1 Cobalt catalysed allylic oxidation of unsaturated steroids |
| 02/28/2002 | WO2001025469A3 Method for preparing steroids modified by yeast fermentation |
| 02/27/2002 | EP0984979B1 Synthesis of 2-alkoxyestradiols |
| 02/26/2002 | US6350739 Methods of prevention and treatment of ischemic damage |
| 02/21/2002 | US20020022609 Orally active androgens |
| 02/14/2002 | WO2001030802A3 Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies |
| 02/14/2002 | US20020019547 Skin disorders; reacting retinol with chloroformate compound |
| 02/07/2002 | WO2002010188A1 16alpha-methyl or ethyl substituted estrogens |
| 02/07/2002 | US20020016316 Novel estrogenic compounds |
| 02/06/2002 | EP0776663B1 Remedy for myotonic dystrophy |
| 01/31/2002 | WO2002007719A1 Use of estramustine phosphate in the treatment of bone metastasis |
| 01/31/2002 | US20020012710 Cancer chemopreventive mixture comprising pomegranate seed oil product and pomegranate juice product |
| 01/31/2002 | US20020012694 For delivery of 7 alpha -methyl-19-nortestosterone (MENT) |
| 01/31/2002 | CA2412392A1 Use of estramustine phosphate in the treatment of bone metastasis |
| 01/24/2002 | WO2001014405A3 Methods of obtaining 2-methoxyestradiol of high purity |
| 01/24/2002 | US20020010166 Crystalline progestagens |
| 01/23/2002 | EP1173182A2 Use of estrone derivatives as antitumour agents |
| 01/17/2002 | US20020006526 Aluminum silicon carbide and copper clad material and manufacturing process |
| 01/16/2002 | EP1172371A1 Process for the preparation of steroid derivatives |
| 01/10/2002 | WO2002002589A1 Novel antiandrogenic agent |
| 01/10/2002 | WO2002002486A1 Process for the preparation of polyhydric alcohols |
| 01/03/2002 | WO2002000619A2 Alkyl ether modified polycyclic compounds having a terminal phenol as cell protecting agents |
| 01/03/2002 | WO2002000225A1 7-hydroxyepiandrosterone having neuroprotective activity |
| 01/03/2002 | WO2001058919A9 Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one |
| 01/03/2002 | US20020002156 Androgenic steroid compounds and a method of making and using the same |
| 01/03/2002 | CA2413552A1 Alkyl ether modified polycyclic compounds having a terminal phenol as cell protecting agents |